3X Blend Tesamorelin (5mg) / MGF (500mcg) / Ipamorelin (2.5mg)

Description

A three-component co-formulation of Tesamorelin, MGF (IGF-1Ec), and Ipamorelin supplied for controlled research environments. Suitable for studies exploring GHRH-receptor, IGF-1Ec–related, and ghrelin (GHS-R1a)–receptor signaling pathways in model systems.

Composition

• Tesamorelin: 5 mg

• MGF (IGF-1Ec): 500 mcg

• Ipamorelin: 2.5 mg

• Appearance: Lyophilized powder in a sealed research vial

Research Focus (non-clinical)

• Combined pathway evaluation of GHRH analog + IGF-1Ec–related peptide + GHS agonist in in-vitro or ex-vivo models

• Assay development, including chromatographic separation of three co-formulated peptides

• Stability characterization of a three-analyte lyophilized blend under laboratory storage conditions

• Method documentation for HPLC/LC-MS identity and purity assessments

Documentation

• Lot-specific COA available (HPLC/LC-MS)

• Batch and lot traceability

Important Notice

• For research use only

• Not for human consumption

• Not intended to diagnose, treat, cure, or prevent any disease

Quality & Manufacturing

• Manufactured in the USA in an ISO 9001–based, cGMP-aligned facility 🇺🇸

• Lot-specific COA (HPLC/LC-MS) with verification key

• Third-party verification link provided per lot (Janoshik)

• Lyophilized for transit stability; batch traceable

• Tamper-evident seal; lot & test date on each vial

• No MOQ for online orders

• Bulk orders for physical locations start at 25-unit minimum